Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry
World Journal of Urology · 2025
DOI: 10.1007/s00345-024-05421-3 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift World Journal of Urology, 2025. Verfasst von Wei Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8519, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Nomograms, Kidney Neoplasms, C-Reactive Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Preoperative C-reactive protein (CRP) is a valuable prognostic biomarker in nonmetastatic clear cell renal cell carcinoma (nmccRCC). Incorporation of CRP into prognostic models may improve the prediction of oncologic outcomes. Herein, we aimed to develop and validate prognostic nomograms and an integrated software incorporating preoperative CRP level in nmccRCC. METHODS: An international multi-institutional database was retrospectively analyzed for nmccRCC patients undergoing surgery. A total of 2284 patients were enrolled and randomly allocated to training (n = 1599, 70%) and validation (n= 685, 30%) cohorts. Nomograms predicting overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were developed in the training cohort using multivariable Cox regression, including preoperative CRP levels and other clinical factors. An integrated software was also created. The validation cohort was used to assess the performance of these nomograms. RESULTS: Following a median follow-up of 5.9 years, 318 (13.92%) patients died of any cause, 109 (4.77%) died of renal cancer, and 282 (12.35%) developed recurrence. The median (interquartile range) preoperative CRP level was 1.90 (0.80-5.68) mg/L. A high CRP level was independently associated with worse OS, CSS, and RFS. The nomograms and integrated software incorporating CRP significantly improved prediction accuracy compared with CRP alone. The C-indices for nomograms were 0.74 (95%CI, 0.69-0.80) for OS, 0.87 (0.82-0.93) for CSS, and 0.77 (0.71-0.82) for RFS in the validation cohort. Acceptable calibration was demonstrated at 12/36/60 months for OS, CSS, and RFS. CONCLUSIONS: The prognostic nomograms and the user-friendly integrated software incorporating preoperative CRP level may facilitate individualized risk stratification and treatment planning for patients with nmccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8519, Japan.
- Department of Urology, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8519, Japan. hjtauro@tmd.ac.jp.
- Department of Urology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
- Department of Urology, University of California San Diego School of Medicine, La Jolla, CA, USA.
- Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Zitieren
APA
Chen, W., Tanaka, H., Kobayashi, M., Fukuda, S., Nakayama, A., Meagher, M. F., Greenwald, R., Schmeusser, B., Nicase, E., Waseda, Y., Yoshida, S., Derweesh, I. H., Master, V. A., Fujii, Y., & Saito, K. (2025). Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry. World Journal of Urology. https://doi.org/10.1007/s00345-024-05421-3
Vancouver
Chen W, Tanaka H, Kobayashi M, Fukuda S, Nakayama A, Meagher MF, et al. Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry. World Journal of Urology. 2025. doi:10.1007/s00345-024-05421-3
BibTeX
@article{Chen2025,
author = {Chen, Wei and Tanaka, Hajime and Kobayashi, Masaki and Fukuda, Shohei and Nakayama, Akinori and Meagher, Margaret F and Greenwald, Rachel and Schmeusser, Benjamin and Nicase, Edouard and Waseda, Yuma and Yoshida, Soichiro and Derweesh, Ithaar H and Master, Viraj A and Fujii, Yasuhisa and Saito, Kazutaka},
title = {Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-024-05421-3}
}
EUVIMED